Glycogen Storage Disease Type V Completed Phase 2 Trials for Triheptanoin (DB11677)

Also known as: McArdle Disease / McArdles disease / Glycogenosis type V / McArdle's disease / Type V glycogen storage disease / GSD V

IndicationStatusPhase
DBCOND0002597 (Glycogen Storage Disease Type V)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02432768The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V)Treatment